JAMES PIKE: Open Payments
NPI 1366443400 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 12 payments from 3 companies in 2025. Trend: 2023 $698 · 2024 $974 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $266 |
| GlaxoSmithKline, LLC. | 6 | $256 |
| Ferring Pharmaceuticals Inc. | 3 | $53 |
Products named: NUCALA, FASENRA, AREXVY, TEZSPIRE, ADSTILADRIN, BREZTRI, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
